MRMD
MariMed Inc. OTC Listed Aug 3, 2012$0.09
Mkt Cap $34.7M
52w Low $0.06
14.0% of range
52w High $0.23
50d MA $0.08
200d MA $0.10
P/E (TTM)
-2.4x
EV/EBITDA
13.3x
P/B
0.7x
Debt/Equity
1.9x
ROE
-19.9%
P/FCF
5.3x
RSI (14)
—
ATR (14)
—
Beta
1.15
50d MA
$0.08
200d MA
$0.10
Avg Volume
545.7K
About
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Ed…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | AMC | -0.01 | 0.01 | +200.0% | 0.08 | -7.5% | -2.9% | +4.3% | -1.2% | -2.5% | -5.5% | — |
| Nov 5, 2025 | AMC | -0.01 | -0.01 | +0.0% | 0.11 | +3.1% | -11.0% | -5.3% | -0.2% | -7.7% | -16.3% | — |
| Aug 6, 2025 | AMC | -0.01 | -0.00 | +68.0% | 0.11 | +0.9% | -11.5% | -10.6% | +15.6% | +7.4% | +19.3% | — |
| May 7, 2025 | AMC | -0.01 | -0.01 | +0.0% | 0.10 | -1.0% | -3.2% | -6.9% | -16.7% | -16.2% | -16.1% | — |
| Mar 5, 2025 | AMC | -0.01 | -0.01 | +0.0% | 0.12 | +7.7% | -4.5% | -5.0% | -8.5% | -10.9% | -7.3% | — |
| Nov 6, 2024 | AMC | -0.00 | -0.00 | -97.7% | 0.15 | -5.0% | -1.6% | +8.6% | -3.7% | +10.6% | +13.0% | — |
| Aug 7, 2024 | AMC | -0.00 | -0.00 | -100.9% | 0.17 | -3.0% | +3.4% | +5.7% | +29.8% | +52.0% | +64.8% | — |
| May 8, 2024 | AMC | -0.00 | -0.00 | -98.3% | 0.29 | +0.5% | -5.2% | -9.5% | -8.7% | -12.1% | -12.5% | — |
| Mar 6, 2024 | AMC | — | -0.03 | — | 0.24 | +9.0% | -2.1% | +4.1% | -4.3% | -15.0% | -11.9% | — |
| Nov 8, 2023 | AMC | -0.01 | -0.01 | -100.0% | 0.32 | -3.1% | -0.4% | +2.5% | -0.9% | -0.9% | -6.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28 | BTIG | Maintains | Buy → Buy | — | $0.53 | $0.53 | +0.0% | -2.3% | +3.8% | +1.9% | -3.8% | -1.9% |
Recent Filings
8-K
Unknown — 8-K Filing
MariMed achieved sixth consecutive year of positive adjusted EBITDA with revenue growth despite industry headwinds, signaling operational resilience and improved financial health that supports long-term viability.
Mar 11
8-K · 1.01
!! High
MariMed Inc. -- 8-K 1.01: Material Agreement
MariMed Inc. agreed to exchange assets valued at $14.2 million, potentially reshaping its portfolio and operational focus while affecting shareholder value through asset reallocation.
Mar 2
Data updated apr 27, 2026 10:33pm
· Source: massive.com